Drug intelligence / Profile preview

acetaminophen + pamabrom

Development stage
Unknown
Lead developer
Hq Speciality Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Acetaminophen + pamabrom is an over-the-counter combination drug used primarily for the temporary relief of menstrual symptoms including cramps, backache, headache, bloating, and water-weight gain. Acetaminophen is a widely used analgesic and antipyretic that blocks pain impulse generation and inhibits prostaglandin synthesis in the central nervous system, thereby reducing pain and fever. Pamabrom is a mild xanthine diuretic that promotes increased urine output to decrease water retention and alleviates bloating. The combination targets the primary symptoms related to menstruation. This combo has FDA approval for these indications. Evidence for efficacy is established for acetaminophen, though robust comparative data versus NSAIDs are limited[1][3][4][5][10].

Brand names
Midol TeenPainaid PMF Premenstrual FormulaWomen's Tylenol Multi-Symptom Menstrual ReliefBackAid MaxCramp TabsMidol Caffeine FreeMidol Teen FormulaTylenol Women's Menstrual Relief
Other names
acetaminophen/pamabrom
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PTGES (Microsomal prostaglandin E synthase-1)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on acetaminophen + pamabrom.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acetaminophen + pamabrom.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call